Central SC Alliance Study Highlights Life Sciences Industry in State

A new study commissioned by the Central SC Alliance (CSCA) identifies advanced manufacturing and supply chain development as Central South Carolina’s strongest near-term opportunities for attracting life sciences investment.

The study highlights the eight-county region’s established pharmaceutical manufacturing base, experienced workforce, research capabilities, and proximity to major Southeastern life sciences markets as key competitive advantages.

“We see tremendous opportunity for Central South Carolina in life sciences, but we also want to be deliberate about where we can compete and win,” said Jason Giulietti, president and CEO of the CSCA. “This study gives us a clearer picture of the strengths already here and a roadmap for pursuing the next investment.”

Pharmaceutical manufacturers, including Ritedose and Nephron Pharmaceuticals, have established and expanded operations in the region, strengthening its capabilities in regulated pharmaceutical production, sterile manufacturing, packaging and distribution. Combined with Central South Carolina’s broader manufacturing and logistics expertise, these assets position the region to compete for additional life sciences investment.

The findings come as South Carolina’s life sciences industry continues to expand. According to the study, the sector generates an estimated $20.1 billion in annual economic impact, supports approximately 63,000 jobs statewide and is growing at four times the statewide average employment rate.

Beyond manufacturing, the study identifies research, health care, and workforce development as important contributors to the region’s long-term growth potential. The Midlands accounts for 30 percent of South Carolina’s National Institutes of Health funding, while the University of South Carolina, regional health systems, and technical colleges provide research, commercialization, clinical and workforce development capabilities.

The study also identifies clinical and digital health as potential areas for future growth, supported by continued collaboration among academic institutions, health care providers, and private industry.

“Life sciences growth depends on connecting research with talent, clinical partners and industry,” said Dr. Stephen Cutler, vice president for economic development and dean of the College of Pharmacy, University of South Carolina. “USC is an important part of that ecosystem, and we have an opportunity to build on those connections to advance innovation and support the sector’s growth across the region.”